series-b
Stage
2018
Founded
1
Investors
About
Alpheus Medical is developing a non-invasive sonodynamic therapy (SDT) that combines a tumor-accumulating drug with low-intensity ultrasound to treat glioblastoma and other solid tumors. This approach aims to activate the drug selectively within tumor cells, minimizing systemic exposure and offering a potential new treatment option for aggressive cancers.
Explore Alpheus Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.